NTT Com Launches Enterprise Cloud WebRTC Platform Globally
NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TOKYO:9432), announced today the global launch of its Enterprise Cloud WebRTC Platform (ECL WebRTC), a service enabling the same-day deployment of online real-time communication functions such as voice & video communications and data transmission capabilities on smartphones, tablets and web applications.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170912005815/en/
Figure (Graphic: Business Wire)
The ECL WebRTC platform offers the following benefits:
- Software Development Kits (SDKs), offering video, voice and data transmission capabilities; the service will deliver four kinds of SDKs compatible with web browsers, iOS, Android or IoT.
- By equipping applications and websites with ECL WebRTC, customers can quickly deploy real-time communication functions such as multi-person video & voice conferencing, as well as data transmission.
- NTT Com supplies and operates all server infrastructure required for WebRTC; customers can focus on their own service development and delivery.
- The service will be made available to enterprises via a subscription plan providing full technical support and a Service Level Agreement offering 99.99% availability; start-up enterprises and developers can sign up online for free-of-charge plans offering limited capacity usage (please see the Appendix for more information).
ECL WebRTC is an NTT Com service that operates servers required for the use of Web Real-Time Communication (WebRTC) capabilities, the standardized technology to realize real-time communication, and that provides software development kit (SDK). WebRTC is a technology that allows web browsers and iOS, Android or IoT devices to send and receive real-time media, demand for which has been driven by the increase in remote working, teleconferencing and distance learning, as well as the growth of online call centers and online translation. In 2013 NTT Com launched SkyWay, Japan’s first WebRTC platform, now used by approximately 5,000 developers, 8,000 applications and 300,000 users. To meet the evolving needs of the marketplace, NTT Com has now launched ECL WebRTC, a fully-fledged commercial service based on the technologies used in SkyWay.
Enterprise Cloud WebRTC Platform Official Site
NTT Communications to Release Trial of SkyWay WebRTC Platform with
TURN Feature (press release on January 27, 2015):
NTT Communications Offers World’s 1st Speech-Recognition API for
Multiple Browsers at No Charge (press release on July 28, 2015):
About NTT Communications Corporation
NTT Communications provides consultancy, architecture, security and
cloud services to optimize the information and communications technology
(ICT) environments of enterprises. These offerings are backed by the
company’s worldwide infrastructure, including the leading global tier-1
IP network, the Arcstar Universal One™ VPN network reaching 196
countries/regions, and 140 secure data centers worldwide. NTT
Communications’ solutions leverage the global resources of NTT Group
companies including Dimension Data, NTT DOCOMO and NTT DATA.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com | LinkedIn@NTT Com
Functions of ECL WebRTC (SDK/Server API)
Server API: Signaling, STUN, TURN, SFU (optional services)
Signaling: exchanges information including IP address and port numbers required for connection between devices.
STUN: obtains global IP address and port numbers of the device.
TURN: enables the use of WebRTC in network environments where P2P communication cannot be used, such as enterprise networks, via data relaying.
SFU: A type of media server that distributes data received from one device to other devices and enables communication between a greater number of people. SFU reduces encoding load on the device and bandwidth, as well as the quantity of sent data when communication is with more than three people.
IoT SDK β version: SDK for developing Linux/Raspberry Pi applications.
|Fee-Liable Plans||Free of Charge Plans|
|Price||Basic||2.480JPY per min, with an upper limit of 100,000 JPY per month*||-|
Free of charge for up to one million events, 100,000 JPY thereafter
|TURN/SFU||40 JPY/GB per one In/Out||-|
|Limit of use||Number of times of Signaling||-||Up to 500,000 times per month|
|Amount of TURN||-||500GB per month|
|Amount of SFU||-||500GB per month|
|Support||Ticket support and developers’ community||Developers’ community only|
* The basic fee will be charged for each tenant. Customers can make more than one API key for WebRTC in each tenant.
Mr. Yasumasa Morita / Mr. Masayuki Hayashi / Ms. Yuko Tomita, +81 3 6733 9521
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 14:00 | Tiedote
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 11:10 | Tiedote
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 18:13 | Tiedote
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 17:00 | Tiedote
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 16:41 | Tiedote
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 15:00 | Tiedote
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme